BACKGROUND: Respiratory distress is a common symptom of patients transported to hospitals by emergency medical services (EMS) personnel. The benefit of advanced life support for such patients has not been established. METHODS: The Ontario Prehospital Advanced Life Support (OPALS) Study was a controlled clinical trial that was conducted in 15 cities before and after the implementation of a program to provide advanced life support for patients with out-of-hospital respiratory distress. Paramedics were trained in standard advanced life support, including endotracheal intubation and the administration of intravenous drugs. RESULTS: The clinical characteristics of the 8138 patients in the two phases of the study were similar. During the first phase, no patients were treated by paramedics trained in advanced life support; during the second phase, 56.6% of patients received this treatment. Endotracheal intubation was performed in 1.4% of the patients, and intravenous drugs were administered to 15.0% during the second phase. This phase of the study was also marked by a substantial increase in the use of nebulized salbutamol and sublingual nitroglycerin for the relief of symptoms. The rate of death among all patients decreased significantly, from 14.3% to 12.4% (absolute difference, 1.9%; 95% confidence interval [CI], 0.4 to 3.4; P=0.01) from the basic-life-support phase to the advanced-life-support phase (adjusted odds ratio, 1.3; 95% CI, 1.1 to 1.5). CONCLUSIONS: The addition of a specific regimen of out-of-hospital advanced-life-support interventions to an existing EMS system that provides basic life support was associated with a decrease in the rate of death of 1.9 percentage points among patients with respiratory distress. Copyright 2007 Massachusetts Medical Society.
BACKGROUND: Respiratory distress is a common symptom of patients transported to hospitals by emergency medical services (EMS) personnel. The benefit of advanced life support for such patients has not been established. METHODS: The Ontario Prehospital Advanced Life Support (OPALS) Study was a controlled clinical trial that was conducted in 15 cities before and after the implementation of a program to provide advanced life support for patients with out-of-hospital respiratory distress. Paramedics were trained in standard advanced life support, including endotracheal intubation and the administration of intravenous drugs. RESULTS: The clinical characteristics of the 8138 patients in the two phases of the study were similar. During the first phase, no patients were treated by paramedics trained in advanced life support; during the second phase, 56.6% of patients received this treatment. Endotracheal intubation was performed in 1.4% of the patients, and intravenous drugs were administered to 15.0% during the second phase. This phase of the study was also marked by a substantial increase in the use of nebulized salbutamol and sublingual nitroglycerin for the relief of symptoms. The rate of death among all patients decreased significantly, from 14.3% to 12.4% (absolute difference, 1.9%; 95% confidence interval [CI], 0.4 to 3.4; P=0.01) from the basic-life-support phase to the advanced-life-support phase (adjusted odds ratio, 1.3; 95% CI, 1.1 to 1.5). CONCLUSIONS: The addition of a specific regimen of out-of-hospital advanced-life-support interventions to an existing EMS system that provides basic life support was associated with a decrease in the rate of death of 1.9 percentage points among patients with respiratory distress. Copyright 2007 Massachusetts Medical Society.
Authors: Matthew E Prekker; Laura C Feemster; Catherine L Hough; David Carlbom; Kristina Crothers; David H Au; Thomas D Rea; Christopher W Seymour Journal: Acad Emerg Med Date: 2014-05 Impact factor: 3.451
Authors: Christopher W Seymour; Jeremy M Kahn; Christian Martin-Gill; Clifton W Callaway; Derek C Angus; Donald M Yealy Journal: Acad Emerg Med Date: 2014-05 Impact factor: 3.451
Authors: Christopher W Seymour; Roger A Band; Colin R Cooke; Mark E Mikkelsen; Julie Hylton; Tom D Rea; Christopher H Goss; David F Gaieski Journal: J Crit Care Date: 2010-04-08 Impact factor: 3.425
Authors: David R Janz; Matthew W Semler; Aaron M Joffe; Jonathan D Casey; Robert J Lentz; Bennett P deBoisblanc; Yasin A Khan; Jairo I Santanilla; Itay Bentov; Todd W Rice Journal: Chest Date: 2017-09-14 Impact factor: 9.410
Authors: Daniel W Spaite; Bentley J Bobrow; Uwe Stolz; Duane Sherrill; Vatsal Chikani; Bruce Barnhart; Michael Sotelo; Joshua B Gaither; Chad Viscusi; P David Adelson; Kurt R Denninghoff Journal: Acad Emerg Med Date: 2014-08-11 Impact factor: 3.451